The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Somnath Chatterjee
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Somnath Chatterjee, Promoter, Chairman and Joint Managing Director of Suraksha Diagnostic, has bought 7,800 equity shares of the company through an open market purchase on 18 August 2025. His holding rose from 26,46,968 shares (5.082%) to 26,54,768 shares (5.097%) of the company's equity capital. The filing was made under Regulation 29(2) of SEBI's Takeover Regulations and disclosed to BSE and NSE. The total paid-up equity capital of the company remained unchanged at 5,20,80,758 shares of ₹2 each.
This is a small, routine purchase by a promoter and signals continued insider confidence in the company, though the size (just 7,800 shares, 0.015% of capital) is too small to materially move the stock price or shift control.